Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1478677
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1478677
Breast Cancer Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Chemotherapy, Hormonal Therapy, Targeted Therapy); By Cancer Type; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global Breast Cancer Therapy market size is expected to reach USD 63.13 billion by 2032, according to a new study by Polaris Market Research. The report "Breast Cancer Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Chemotherapy, Hormonal Therapy, Targeted Therapy); By Cancer Type; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The factors propelling the breast cancer therapy market forward, are the rising occurrence of breast cancer, technological advancements, heightened demand for personalized medicine, government initiatives, and augmented healthcare spending. Additionally, the expanding drug pipeline for treatment is fostering competition and attracting investment in the market. As research progresses, we can expect the emergence of new drugs and treatment alternatives to drive further market growth. For instance, in April 2023, England plans to offer thousands of breast cancer patients a pioneering oncology drug designed to target a hereditary genetic mutation.
Immunotherapy, especially checkpoint inhibitors, has demonstrated potential in treating specific types of breast cancer by activating the immune system to identify and combat cancer cells. For instance, PD-1 inhibitors like pembrolizumab and nivolumab are undergoing clinical trials for triple-negative breast cancer (TNBC), which is typically more aggressive and challenging to treat with conventional methods. There is also ongoing exploration of combining immunotherapy with other treatments, such as chemotherapy or targeted therapy, to enhance outcomes for breast cancer patients.
In emerging markets across Asia, Africa, and Latin America, there is a rising awareness of breast cancer alongside efforts to improve healthcare infrastructure. These efforts include initiatives to bolster early detection, diagnosis, and treatment of breast cancer. With increasing disposable incomes in these regions, more individuals can access and afford advanced treatments, thereby presenting substantial growth opportunities for providers of the breast cancer therapy market.
Breast Cancer Therapy Market Report Highlights
The targeted therapy design segment dominated the market in 2023, driven by significant transformation with the introduction of targeted medicines, such as novel medications that target other cellular pathways involved in the growth and survival of breast cancer are also showing promise in clinical studies.
The hormone receptor segment led the market in 2023 and is expected to maintain its dominance due to the rising incidence of breast cancer.
North America holds a significant revenue share in the global breast cancer therapy market, driven by the region experiences high incidence of breast cancer, creating a strong demand for effective treatment options.
The global key market players include Novartis AG, Pfizer Inc., Merck KGaA, Janssen Pharmaceuticals, Inc., Celgene Corporation, Inc., Genzyme Corp., F. Hoffmann-La Roche Ltd., AstraZeneca, AbbVie Inc., Bristol-Myers Squibb Company and Macrogenics, Inc.
Polaris Market Research has segmented the Breast Cancer Therapy market report based on therapy, cancer type, distribution channel, and region:
Breast Cancer Therapy, Therapy Outlook (Revenue - USD Billion, 2019 - 2032)
- Chemotherapy
- Hormonal Therapy
- Aromatase Inhibitors
- Estrogen Receptor Down regulators (ERDs)
- Selective Estrogen Receptor Modulators (SERMs)
- Targeted Therapy
- Ribociclib
- Palbociclib
- Pertuzumab
- Olaparib
- Abemaciclib
- Ado-Trastuzumab Emtansine
- Everolimus
- Trastuzumab
- Others
- Immunotherapy
- Radiation & Surgery Therapy
Breast Cancer Therapy, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Hormone Receptor
- HER2+
- Others
Breast Cancer Therapy, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)
- Retail Pharmacies
- Hospital Pharmacies
- Others
Breast Cancer Therapy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Product Code: PM1534
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Breast Cancer Therapy Market Insights
- 4.1. Breast Cancer Therapy Market - Distribution Channel Snapshot
- 4.2. Breast Cancer Therapy Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Worldwide Breast Cancer Incidence Rate
- 4.2.1.2. Advancements in Personalized Medicine
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Patent expiry is expected to hinder market expansion
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Breast Cancer Therapy Market Distribution Channel Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Breast Cancer Therapy Market, by Therapy
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 5.3. Chemotherapy
- 5.3.1. Global Breast Cancer Therapy Market, by Chemotherapy, by Region, 2019-2032 (USD Billion)
- 5.4. Hormonal Therapy
- 5.4.1. Global Breast Cancer Therapy Market, by Hormonal Therapy, by Region, 2019-2032 (USD Billion)
- 5.4.2. Aromatase Inhibitors
- 5.4.2.1. Global Breast Cancer Therapy Market, by Aromatase Inhibitors, by Region, 2019-2032 (USD Billion)
- 5.4.3. Estrogen Receptor Down regulators (ERDs)
- 5.4.3.1. Global Breast Cancer Therapy Market, by Estrogen Receptor Down regulators (ERDs), by Region, 2019-2032 (USD Billion)
- 5.4.4. Selective Estrogen Receptor Modulators (SERMs)
- 5.4.4.1. Global Breast Cancer Therapy Market, by Selective Estrogen Receptor Modulators (SERMs), by Region, 2019-2032 (USD Billion)
- 5.5. Targeted Therapy
- 5.5.1. Global Breast Cancer Therapy Market, by Targeted Therapy, by Region, 2019-2032 (USD Billion)
- 5.5.2. Ribociclib
- 5.5.2.1. Global Breast Cancer Therapy Market, by Ribociclib, by Region, 2019-2032 (USD Billion)
- 5.5.3. Palbociclib
- 5.5.3.1. Global Breast Cancer Therapy Market, by Palbociclib, by Region, 2019-2032 (USD Billion)
- 5.5.4. Pertuzumab
- 5.5.4.1. Global Breast Cancer Therapy Market, by Pertuzumab, by Region, 2019-2032 (USD Billion)
- 5.5.5. Olaparib
- 5.5.5.1. Global Breast Cancer Therapy Market, by Olaparib, by Region, 2019-2032 (USD Billion)
- 5.5.6. Abemaciclib
- 5.5.6.1. Global Breast Cancer Therapy Market, by Abemaciclib, by Region, 2019-2032 (USD Billion)
- 5.5.7. Ado-Trastuzumab Emtansine
- 5.5.7.1. Global Breast Cancer Therapy Market, by Ado-Trastuzumab Emtansine, by Region, 2019-2032 (USD Billion)
- 5.5.8. Everolimus
- 5.5.8.1. Global Breast Cancer Therapy Market, by Everolimus, by Region, 2019-2032 (USD Billion)
- 5.5.9. Trastuzumab
- 5.5.9.1. Global Breast Cancer Therapy Market, by Trastuzumab, by Region, 2019-2032 (USD Billion)
- 5.5.10. Others
- 5.5.10.1. Global Breast Cancer Therapy Market, by Others, by Region, 2019-2032 (USD Billion)
- 5.6. Immunotherapy
- 5.6.1. Global Breast Cancer Therapy Market, by Immunotherapy, by Region, 2019-2032 (USD Billion)
- 5.7. Radiation & Surgery Therapy
- 5.7.1. Global Breast Cancer Therapy Market, by Radiation & Surgery Therapy, by Region, 2019-2032 (USD Billion)
6. Global Breast Cancer Therapy Market, by Cancer Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 6.3. Hormone Receptor
- 6.3.1. Global Breast Cancer Therapy Market, by Hormone Receptor, by Region, 2019-2032 (USD Billion)
- 6.4. HER2+
- 6.4.1. Global Breast Cancer Therapy Market, by HER2+, by Region, 2019-2032 (USD Billion)
- 6.5. Others
- 6.5.1. Global Breast Cancer Therapy Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Breast Cancer Therapy Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 7.3. Retail Pharmacies
- 7.3.1. Global Breast Cancer Therapy Market, by Retail Pharmacies, By Region, 2019-2032 (USD Billion)
- 7.4. Hospital Pharmacies
- 7.4.1. Global Breast Cancer Therapy Market, by Hospital Pharmacies, By Region, 2019-2032 (USD Billion)
- 7.5. Others
- 7.5.1. Global Breast Cancer Therapy Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Breast Cancer Therapy Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Breast Cancer Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Breast Cancer Therapy Market - North America
- 8.3.1. North America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.3.2. North America: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.3. North America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.3.4. Breast Cancer Therapy Market - U.S.
- 8.3.4.1. U.S.: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.3.5. Breast Cancer Therapy Market - Canada
- 8.3.5.1. Canada: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.4. Breast Cancer Therapy Market - Europe
- 8.4.1. Europe: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.3. Europe: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.4.4. Breast Cancer Therapy Market - UK
- 8.4.4.1. UK: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.4.5. Breast Cancer Therapy Market - France
- 8.4.5.1. France: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.5.3. France: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.4.6. Breast Cancer Therapy Market - Germany
- 8.4.6.1. Germany: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.4.7. Breast Cancer Therapy Market - Italy
- 8.4.7.1. Italy: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.4.8. Breast Cancer Therapy Market - Spain
- 8.4.8.1. Spain: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.4.9. Breast Cancer Therapy Market - Netherlands
- 8.4.9.1. Netherlands: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.4.10. Breast Cancer Therapy Market - Russia
- 8.4.10.1. Russia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.5. Breast Cancer Therapy Market - Asia Pacific
- 8.5.1. Asia Pacific: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.5.4. Breast Cancer Therapy Market - China
- 8.5.4.1. China: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.4.3. China: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.5.5. Breast Cancer Therapy Market - India
- 8.5.5.1. India: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.5.3. India: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.5.6. Breast Cancer Therapy Market - Malaysia
- 8.5.6.1. Malaysia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.5.7. Breast Cancer Therapy Market - Japan
- 8.5.7.1. Japan: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.5.8. Breast Cancer Therapy Market - Indonesia
- 8.5.8.1. Indonesia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.5.9. Breast Cancer Therapy Market - South Korea
- 8.5.9.1. South Korea: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.6. Breast Cancer Therapy Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.6.4. Breast Cancer Therapy Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.6.5. Breast Cancer Therapy Market - UAE
- 8.6.5.1. UAE: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.6.6. Breast Cancer Therapy Market - Israel
- 8.6.6.1. Israel: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.6.7. Breast Cancer Therapy Market - South Africa
- 8.6.7.1. South Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.7. Breast Cancer Therapy Market - Latin America
- 8.7.1. Latin America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.7.4. Breast Cancer Therapy Market - Mexico
- 8.7.4.1. Mexico: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.7.5. Breast Cancer Therapy Market - Brazil
- 8.7.5.1. Brazil: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- 8.7.6. Breast Cancer Therapy Market - Argentina
- 8.7.6.1. Argentina: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Novartis AG
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Pfizer Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Merck KGaA
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Janssen Pharmaceuticals, Inc
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Celgene Corporation, Inc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Genzyme Corp
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. F. Hoffmann-La Roche Ltd
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. AstraZeneca
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. AbbVie Inc
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Bristol-Myers Squibb Company
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Macrogenics, Inc
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Celldex Therapeutics
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Onyx Pharmaceuticals Inc.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
Product Code: PM1534
List of Tables
- Table 1 Global Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 2 Global Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 3 Global Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 4 Breast Cancer Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 6 North America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 7 North America: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 8 U.S.: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 9 U.S.: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 10 U.S.: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 11 Canada: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 12 Canada: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 13 Canada: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 14 Europe: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 15 Europe: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 16 Europe: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 17 UK: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 18 UK: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 19 UK: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 20 France: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 21 France: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 22 France: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 23 Germany: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 24 Germany: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 25 Germany: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 26 Italy: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 27 Italy: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 28 Italy: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 29 Spain: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 30 Spain: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 31 Spain: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 32 Netherlands: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 33 Netherlands: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 34 Netherlands: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 35 Russia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 36 Russia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 37 Russia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 41 China: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 42 China: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 43 China: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 44 India: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 45 India: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 46 India: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 47 Malaysia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 48 Malaysia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 49 Malaysia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 50 Japan: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 51 Japan: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 52 Japan: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 53 Indonesia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 54 Indonesia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 55 Indonesia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 56 South Korea: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 57 South Korea: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 58 South Korea: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 65 UAE: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 66 UAE: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 67 UAE: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 68 Israel: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 69 Israel: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 70 Israel: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 71 South Africa: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 72 South Africa: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 73 South Africa: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 74 Latin America: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 75 Latin America: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 76 Latin America: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 77 Mexico: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 78 Mexico: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 79 Mexico: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 80 Brazil: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 81 Brazil: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 82 Brazil: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 83 Argentina: Breast Cancer Therapy Market, by Therapy, 2019-2032 (USD Billion)
- Table 84 Argentina: Breast Cancer Therapy Market, by Cancer Type, 2019-2032 (USD Billion)
- Table 85 Argentina: Breast Cancer Therapy Market, by Distribution Channel, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Breast Cancer Therapy Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Cancer Type
- Figure 7. Global Breast Cancer Therapy Market, by Cancer Type, 2022 & 2032 (USD Billion)
- Figure 8. Market by Therapy
- Figure 9. Global Breast Cancer Therapy Market, by Therapy, 2022 & 2032 (USD Billion)
- Figure 10. Market by Distribution Channel
- Figure 11. Global Breast Cancer Therapy Market, by Distribution Channel, 2022 & 2032 (USD Billion)
- Figure 12. Breast Cancer Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Breast Cancer Therapy Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.